Divalproex Sodium Tablet, Delayed Release
Product Images NDC 70518-4575

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-4575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 01)

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 02)

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 03)

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 04)

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 05)

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of Divalproex Sodium Delayed Release 500mg tablets which come in a quantity of 30 tablets. The tablets are repackaged by RemedyRepack Inc. and manufactured by BluePoint Labs in Ahmedabad, India. The usual dosage instructions are available in the insert. It is important to keep the medication out of reach of children and store it at temperatures between 20-25°C (68-77°F) with excursions permitted between 15-30°C (59-86°F) as per USP standards.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.